Cargando...
Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature
Crizotinib is a first-line tyrosine kinase inhibitor used for the treatment of metastatic lung cancer. Crizotinib-induced hepatotoxicity is a rare event. We report a case of a 46-year-old female with a history of metastatic lung cancer who presented with acute liver failure after being on crizotinib...
Guardado en:
| Publicado en: | Case Reports Hepatol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085870/ https://ncbi.nlm.nih.gov/pubmed/32231818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8247960 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|